Concepedia

Efficacy and safety of combination targeted therapies in immune-mediated inflammatory disease: the COMBIO study

Lucas Guillo, B. Flachaire, Jérôme Avouac, Catherine Dong, Maria Nachury, Guillaume Bouguen, Anthony Buisson, Ludovic Caillo, Mathurin Fuméry, Cyrielle Gilletta,

Digestive and Liver Disease · 2022 · 32 citations · 22 references

DOIFull text

Open access

Concepts

References

22

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

Jean‐Frédéric Colombel, William J. Sandborn, Walter Reinisch et al. · New England Journal of Medicine · 2010 · 3.1K citations · Full text

, , +14

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

Brian G. Feagan, William J. Sandborn, Christopher Gasink et al. · New England Journal of Medicine · 2016 · 1.8K citations · Full text

, , +17

Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis

Remo Panaccione, Subrata Ghosh, Stephen Middleton et al. · Gastroenterology · 2013 · 961 citations

, , +12

Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo‐controlled trial (ASSERT)

Désirée van der Heijde, Ben A. C. Dijkmans, Piet Geusens et al. · Arthritis & Rheumatism · 2005 · 861 citations

, , +14

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

Bruce E. Sands, Laurent Peyrin‐Biroulet, Edward V. Loftus et al. · New England Journal of Medicine · 2019 · 725 citations · Full text

, , +12